Duchenne Muscular Dystrophy, a rare genetic condition, leads to the gradual loss of muscle strength in boys, often necessitating the use of wheelchairs by the early teenage years.
One boy from Columbiana County, Ohio, has found hope in groundbreaking gene therapy.
At just nine years old, Jerick MayRobb is already a fighter.
This weekend, he stepped up to the mound not just for the game but for every kid battling Duchenne Muscular Dystrophy.
Jerick learned he had Duchenne at four years old. By the age of six, he joined an innovative clinical trial at Nationwide Children’s Hospital in Columbus.
Now nine, he’s not just surviving; he’s thriving.
“I’ve been having a lot of fun and I’m really happy that I’m not in a wheelchair yet,” he said. “And hopefully I’m never in one.”
Jerick’s family watched as he battled through treatment.
“Seeing him maintain such a positive attitude through it all… I doubt that, as an adult, I could have faced it with the same smile he did,” his dad, Zack MayRobb, remarked.
Nowadays, Jerick enjoys biking, playing basketball, and baseball, much like his idol, Cleveland Guardians star José Ramírez, activities that once seemed unattainable.
“It feels as though every day is a dream realized at this stage,” his father expressed. “He’s an active team member, scoring in basketball and making significant plays in baseball.”
The MayRobbs know the treatment isn’t a cure, but it’s giving their son something just as precious: time.
“Witnessing things we never anticipated happening in his lifetime has been incredible,” said Jerick’s stepmother, Payton MayRobb. “It truly enhances our appreciation for life with him and life overall.”
At Sunday’s Akron Rubber Ducks Game, nearly 140 people from 36 Akron Children’s families were there just steps from the hospital where many of them receive care to watch Jerick throw out the game’s first pitch.
“It gives them hope in a space that feels hopeless,” said Dr. Kathryn Mosher, director of Akron Children’s Hospital’s neuromuscular program.
For the MayRobbs, that hope is already there.
